Dr Valerie Yang is a Senior Medical Oncologist at OncoCare Cancer Centre, dedicated to providing personalised care to each patient. With over 15 years of clinical experience, she translates cutting-edge approaches into clinical care. She focuses on managing complex cancers, including rare cancers, sarcomas, skin cancers, melanomas, lymphomas, and general oncology.
Dr Yang is also jointly appointed as Group Leader of the Translational Precision Oncology Laboratory at the Institute of Molecular and Cell Biology (IMCB), Adjunct Principal Investigator at the Bioinformatics Institute, A*STAR, Adjunct Assistant Professor at Duke-NUS Medical School, and Visiting Consultant at the National Cancer Centre Singapore. Her translational research bridges real-world data, advanced genomic and spatial technologies, patient-derived models, and functional precision oncology to bring more effective treatments to patients.
Dr Yang has authored over 60 publications and book chapters, which have been presented at major international conferences, including the American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), American Association for Cancer Research (AACR), and the Connective Tissue Oncology Society (CTOS), and others..
A graduate of the MB/PhD programme at the University of Cambridge, Dr Yang has received several awards, including First Prize in an open competition among Cambridge University’s PhD candidates in Biological Sciences and the Sylvia Lawler Prize from the Royal Society of Medicine. She is also a member of a three-person international scholar selection panel for the Gates Cambridge Trust for Biological Sciences and a National Science Scholar under Singapore’s A*STAR scholarship programme. Her clinical training in Internal Medicine and Medical Oncology was completed at leading institutions in Singapore, including the National University Hospital (NUH) and the National Cancer Centre Singapore (NCCS).
Dr Yang has received numerous accolades, including the prestigious National Medical Research Council (NMRC) Transition Award as an Associate Consultant and a S$25 million Open Fund Large Collaborative Grant as Theme Principal Investigator. Internationally, she holds key roles in global networks for rare cancers and sarcomas, representing Singapore in clinical trials and research collaborations with both academic institutions and industry. She also co-chairs the biennial Singapore Sarcoma & Skin Cancers Symposium. Dr Yang has taught at the National University of Singapore (NUS) and Duke-NUS Medical School, and has mentored over 30 students, ranging from science and medical students to Master’s and PhD candidates.
Dr Yang is fluent in English, Mandarin, as well as Bahasa Melayu and Indonesian, ensuring that patients from diverse backgrounds feel heard and supported. She is also a strong advocate for several patient support groups. She has received named referrals for rare cancers and sarcomas from around the world, including Indonesia, Vietnam, Thailand, Cambodia, Myanmar, Japan, Australia, the United Arab Emirates, the United Kingdom, Germany, France, Poland, South Africa, and Inner Mongolia.
